Your browser doesn't support javascript.
loading
Sequence variants associating with urinary biomarkers.
Benonisdottir, Stefania; Kristjansson, Ragnar P; Oddsson, Asmundur; Steinthorsdottir, Valgerdur; Mikaelsdottir, Evgenia; Kehr, Birte; Jensson, Brynjar O; Arnadottir, Gudny A; Sulem, Gerald; Sveinbjornsson, Gardar; Kristmundsdottir, Snaedis; Ivarsdottir, Erna V; Tragante, Vinicius; Gunnarsson, Bjarni; Runolfsdottir, Hrafnhildur Linnet; Arthur, Joseph G; Deaton, Aimee M; Eyjolfsson, Gudmundur I; Davidsson, Olafur B; Asselbergs, Folkert W; Hreidarsson, Astradur B; Rafnar, Thorunn; Thorleifsson, Gudmar; Edvardsson, Vidar; Sigurdsson, Gunnar; Helgadottir, Anna; Halldorsson, Bjarni V; Masson, Gisli; Holm, Hilma; Onundarson, Pall T; Indridason, Olafur S; Benediktsson, Rafn; Palsson, Runolfur; Gudbjartsson, Daniel F; Olafsson, Isleifur; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari.
  • Benonisdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kristjansson RP; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Steinthorsdottir V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Mikaelsdottir E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kehr B; Berlin Institute of Health (BIH), Berlin, Germany.
  • Jensson BO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Arnadottir GA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sulem G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sveinbjornsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kristmundsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Ivarsdottir EV; School of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
  • Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gunnarsson B; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • Runolfsdottir HL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Arthur JG; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • Deaton AM; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Eyjolfsson GI; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Davidsson OB; The Rare Kidney Stone Consortium, Mayo Clinic, Rochester, MN, USA.
  • Asselbergs FW; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Hreidarsson AB; Department of Statistics, Stanford University, Stanford, CA, USA.
  • Rafnar T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Thorleifsson G; Icelandic Medical Center (Laeknasetrid), Laboratory in Mjodd (RAM), Reykjavik, Iceland.
  • Edvardsson V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sigurdsson G; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • Helgadottir A; Durrer Center for Cardiovascular Research, Netherlands Heart Institute, Utrecht, the Netherlands.
  • Halldorsson BV; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
  • Masson G; Farr Institute of Health Informatics Research and Institute of Health Informatics, University College London, London, UK.
  • Holm H; Division of Endocrinology and Metabolic Medicine, Internal Medicine Services, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
  • Onundarson PT; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Indridason OS; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Benediktsson R; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Palsson R; The Rare Kidney Stone Consortium, Mayo Clinic, Rochester, MN, USA.
  • Gudbjartsson DF; Children's Medical Center, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
  • Olafsson I; Division of Endocrinology and Metabolic Medicine, Internal Medicine Services, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
  • Thorsteinsdottir U; Icelandic Heart Association, Kópavogur, Iceland.
  • Sulem P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Hum Mol Genet ; 28(7): 1199-1211, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30476138
ABSTRACT
Urine dipstick tests are widely used in routine medical care to diagnose kidney and urinary tract and metabolic diseases. Several environmental factors are known to affect the test results, whereas the effects of genetic diversity are largely unknown. We tested 32.5 million sequence variants for association with urinary biomarkers in a set of 150 274 Icelanders with urine dipstick measurements. We detected 20 association signals, of which 14 are novel, associating with at least one of five clinical entities defined by the urine dipstick glucosuria, ketonuria, proteinuria, hematuria and urine pH. These include three independent glucosuria variants at SLC5A2, the gene encoding the sodium-dependent glucose transporter (SGLT2), a protein targeted pharmacologically to increase urinary glucose excretion in the treatment of diabetes. Two variants associating with proteinuria are in LRP2 and CUBN, encoding the co-transporters megalin and cubilin, respectively, that mediate proximal tubule protein uptake. One of the hematuria-associated variants is a rare, previously unreported 2.5 kb exonic deletion in COL4A3. Of the four signals associated with urine pH, we note that the pH-increasing alleles of two variants (POU2AF1, WDR72) associate significantly with increased risk of kidney stones. Our results reveal that genetic factors affect variability in urinary biomarkers, in both a disease dependent and independent context.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2019 Tipo del documento: Article